Authors:
Chessell, IP
Grahames, CBA
Michel, AD
Humphrey, PPA
Citation: Ip. Chessell et al., Dynamics of P2X(7) receptor pore dilation: Pharmacological and functional consequences, DRUG DEV R, 53(2-3), 2001, pp. 60-65
Authors:
Hibell, AD
Thompson, KM
Simon, J
Xing, M
Humphrey, PPA
Michel, AD
Citation: Ad. Hibell et al., Species- and agonist-dependent differences in the deactivation-kinetics ofP2X(7) receptors, N-S ARCH PH, 363(6), 2001, pp. 639-648
Citation: Ad. Michel et al., Serum constituents can affect 2 '-& 3 '-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors, BR J PHARM, 132(7), 2001, pp. 1501-1508
Authors:
Simon, J
Vigne, P
Eklund, KM
Michel, AD
Carruthers, AM
Humphrey, PPA
Frelin, C
Barnard, EA
Citation: J. Simon et al., Activity of adenosine diphosphates and triphosphates on a P2Y(T)-type receptor in brain capillary endothelial cells, BR J PHARM, 132(1), 2001, pp. 173-182
Authors:
Michel, AD
Kaur, R
Chessell, IP
Humphrey, PPA
Citation: Ad. Michel et al., Antagonist effects on human P2X(7) receptor-mediated cellular accumulationof YO-PRO-1, BR J PHARM, 130(3), 2000, pp. 513-520
Authors:
Grahames, CBA
Michel, AD
Chessell, IP
Humphrey, PPA
Citation: Cba. Grahames et al., Pharmacological characterization of ATP- and LPS-induced IL-1 beta releasein human monocytes, BR J PHARM, 127(8), 1999, pp. 1915-1921
Authors:
Carruthers, AM
Warner, AJ
Michel, AD
Feniuk, W
Humphrey, PPA
Citation: Am. Carruthers et al., Activation of adenylate cyclase by human recombinant sst(5) receptors expressed in CHO-K1 cells and involvement of G(alpha s) proteins, BR J PHARM, 126(5), 1999, pp. 1221-1229